Provided by Tiger Trade Technology Pte. Ltd.

Iovance Biotherapeutics, Inc.

3.96
-0.1100-2.70%
Post-market: 3.960.00000.00%19:59 EDT
Volume:19.37M
Turnover:76.50M
Market Cap:1.63B
PE:-3.62
High:4.21
Open:4.20
Low:3.81
Close:4.07
52wk High:5.63
52wk Low:1.64
Shares:411.96M
Float Shares:339.00M
Volume Ratio:0.70
T/O Rate:5.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0941
EPS(LYR):-1.0941
ROE:-55.50%
ROA:-27.30%
PB:2.34
PE(LYR):-3.62

Loading ...

Jun 12, 2020

Major Issues Report

8-K - Current report
Jun 09, 2020

Major Issues Report

8-K - Current report
Jun 02, 2020

Major Issues Report

8-K - Current report
May 29, 2020

Major Issues Report

8-K - Current report
May 27, 2020

Major Issues Report

8-K - Current report
May 22, 2020

Major Issues Report

8-K - Current report
May 08, 2020

Major Issues Report

Current report, items 8.01 and 9.01
May 05, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 05, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 25, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 24, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 05, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 04, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 04, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 04, 2019

Major Issues Report

Current report, items 2.02 and 9.01